Fox Chase Cancer Center | Strategic Alliance Partners

Latest from Fox Chase Cancer Center

Researchers Find Ancestry Impacts Effectiveness of Prostate Cancer Drugs

December 04, 2025

Article

Effectiveness of prostate cancer drugs potentially tied to ancestry according to new research data.

Shaping the Future of Care for Neuroendocrine Tumors

November 19, 2025

Article

Fox Chase Cancer Center’s Namrata ‘Neena’ Vijayvergia, MD, an expert in gastrointestinal cancers and rare NETs, was recently recognized by two NET advocacy groups for her contributions to the field.

Researchers Develop New AI Tool That Makes Detection of Skin Cancer More Accurate

November 14, 2025

Article

A new method enhances the ability of artificial intelligence models to detect and diagnose skin cancer in individuals with darker skin.

OncLive’s October Roundup of Key FDA Approvals in Oncology: 4 Decisions to Know

October 31, 2025

Article

Here is your guide to all therapeutic options that were approved by the FDA in October 2025 spanning tumor types.

Fox Chase Cancer Center Breast Program Receives Accreditation for Sixth Consecutive Time

September 11, 2025

Article

The NAPBC has renewed Fox Chase Cancer Center’s accreditation, making it the sixth consecutive time Fox Chase has been honored with this distinction.

Fox Chase Cancer Center Researchers Discover ‘Cell-in-Cell’ Mechanism That Blood Cancer Uses to Evade Treatment

August 19, 2025

Article

Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts.

Fox Chase Cancer Center and Temple Researchers Highlight Need For Molecular Testing in Diagnosing Two Types of Kidney Cancer

August 13, 2025

Article

Genetic testing could help determine differences between rare forms of kidney cancer.

Novel Fox Chase Cancer Center Study Uses New Methods to Show How Fast Breast Cancers Grow and How Surgery Delays Affect Cancer Staging

August 08, 2025

Article

Richard Bleicher, MD, FACS, discusses using a novel method to analyze tumor growth rates.

Fox Chase Cancer Center Researcher Helps Finds Key Resistance Mechanism in Breast Cancer That Could Lead to More Effective Treatment

July 10, 2025

Article

New research from Fox Chase Cancer Center uncovers mechanisms of breast cancer resistance to CDK4/6 inhibitors and offers innovative treatment strategies.

Gene Mutation Could Be Target for ‘Ultrapersonalized’ Therapies in Colon Cancer

June 26, 2025

Article

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene that may play an important role in colon cancer.

Fox Chase Cancer Center Earns Renewal of Prestigious Core Grant from the National Cancer Institute

May 26, 2025

Article

In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and treatment.

Fragmented Care Does Not Affect Survival Outcomes for Retroperitoneal Sarcoma, Fox Chase Cancer Center Study Finds

May 21, 2025

Article

Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment

May 13, 2025

Article

Fox Chase Cancer Center Researcher secures funding to investigate toxicity reduction in bladder cancer treatment.

Fox Chase Cancer Center Researcher Adria Hasan Honored With Scholar-in-Training Award From American Association for Cancer Research

May 02, 2025

Article

Fox Chase Cancer Center researcher Adria Hasan honored with scholar-in-training award from American Association for Cancer Research.

Fox Chase Cancer Center’s Dr. Jonathan Chernoff Elected to Association of American Physicians

April 30, 2025

Article

Jonathan Chernoff, MD, PhD, Cancer Center Director of Fox Chase Cancer Center, was recently elected to the Association of American Physicians (AAP).

Cultural Competency and Respect Are Crucial for Addressing Disparities in Cancer Care

April 23, 2025

Article

Akina Tamaki, MD, highlights treatment considerations, the therapeutic arsenal, and surgical advancements in head and neck cancer.

Subtype-Specific Considerations, Surgical Innovation, and Functional Preservation Are Central to HNSCC Management

April 18, 2025

Article

Akina Tamaki, MD, highlights treatment considerations, the therapeutic arsenal, and surgical advancements in head and neck cancer.

Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer

April 04, 2025

Article

Removing and testing more lymph nodes during surgery was associated with more accurate staging and better survival rates for patients with colon cancer.

Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds

April 01, 2025

Article

Results from a study presented by Fox Chase Cancer Center suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.

Fox Chase Cancer Center’s Jaye Gardiner Receives Research Grant From Uplifting Athletes

March 26, 2025

Article

Jaye Gardiner, PhD, postdoctoral fellow at Fox Chase Cancer Center to receive a grant from the nonprofit Uplifting Athletes during its Young Investigators Draft.